查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854732

醫用迴旋加速器市場：按應用、最終用戶、迴旋加速器類型、產品和分銷管道分類 - 全球預測（2025-2032 年）

Medical Cyclotron Market by Application, End User, Cyclotron Type, Product, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫用迴旋加速器市場規模將達到 8.8731 億美元，複合年成長率為 10.91%。

關鍵市場統計數據
基準年 2024 3.8735億美元
預計年份：2025年 4.3056億美元
預測年份 2032 8.8731億美元
複合年成長率 (%) 10.91%

策略方向明確了醫用迴旋加速器的臨床作用、營運需求以及在現代放射性藥物供應鏈中的整合。

醫用迴旋加速器處於臨床需求與工業能力的交會點，能夠生產支撐現代診斷和治療流程的短壽命放射性同位素。加速器設計、自動化和放射化學領域的最新進展縮短了生產週期，提高了局部同位素生產的可行性，並減少了對廣泛分銷網路的依賴。本文旨在為理解迴旋加速器技術如何與放射性藥物工作流程、醫院核子醫學科和契約製造運作結合奠定基礎。

此外，設施佈局、屏蔽和法規遵循等營運因素也會影響資本規劃和日常生產效率。以患者為中心的促進因素，例如對精準診斷示踪劑和標靶治療的需求，正在加速對能夠與臨床日程同步的靈活同位素生產的需求。因此，從醫院管理者到製藥研發人員等相關人員都在調整其採購和臨床供應策略，以充分利用現代迴旋加速器部署所固有的營運優勢。

本執行摘要探討了重新定義迴旋加速器部署的技術、商業性和監管力量，重點關注可操作的見解，以支持採購決策、臨床準備以及放射性藥物生態系統中的夥伴關係。

技術創新、臨床需求和不斷演變的法律規範如何融合，從而重塑迴旋加速器的部署模式和運作策略？

受技術成熟、臨床需求和不斷變化的監管預期等因素的驅動，醫用迴旋加速器領域正經歷顯著變革。緊湊型迴旋加速器架構和更高的能源效率拓展了其適用安裝地點的範圍，使影像中心和醫院能夠優先考慮現場生產而非集中供應模式。同時，標靶處理、放射化學模組和品管系統的自動化降低了對操作人員的依賴性，並提高了實驗結果的可重複性。

同時，放射性藥物價值鏈的垂直整合程度日益提高，製藥公司和契約製造紛紛投資建立自有生產能力，以確保治療和診斷示蹤劑的持續供應。迴旋加速器原始設備製造商 (OEM) 與放射化學供應商之間的策略夥伴關係進一步促進了這種垂直整合，加速了技術轉移並縮短了檢驗週期。法律規範也在適應新的生產模式。檢查機構和認證機構正在更新其對設施資格確認、製程驗證和無菌保證的要求，從而更加重視在計劃早期規劃階段就納入合規性設計。

總而言之，這些轉變體現了技術能力、臨床需求和監管要求的融合，有利於可快速擴展和驗證的適應性強的迴旋加速器解決方案。最終結果是風險和機會的重新分配：臨床機構對其同位素供應擁有更大的控制權，而製造商和服務供應商必須證明其穩定性和合規性，才能贏得長期合作關係。

了解近期關稅驅動的貿易政策轉變如何改變迴旋加速器基礎設施的採購經濟、供應鏈韌性和售後市場支持。

近期貿易政策調整引發的關稅措施，為迴旋加速器系統及配套設備的採購與供應帶來了顯著的複雜動態。影響進口零件、精密加工和部分電子子系統的關稅提高了到岸成本，獎勵供應商重新評估其全球生產佈局。這使得採購負責人更加關注總體擁有成本分析，該分析涵蓋關稅、跨境物流和潛在的前置作業時間變化。

在供應商層面，製造商正透過供應商多元化、組裝以及在某些情況下與區域性加工商合作來應對關稅影響。這些策略性措施有助於保護淨利率並維持價格競爭力，但同時也為從新的司法管轄區採購零件時的品管和監管文件帶來了挑戰。對於醫院和診斷影像中心的採購者而言，關稅環境也促使他們考慮基於服務的安排和租賃模式，這些模式可以平滑資本支出並將某些外匯和貿易風險轉移給供應商。

在營運層面，關稅會對備件供應和售後服務合約產生下游影響。使用舊有系統的設施可能會面臨更長的更換零件採購週期，從而增加成本。此外，目前的貿易環境預示著供應鏈中斷的風險，並凸顯了包含價格上漲條款、優先採購選項以及買賣雙方風險共擔機制的穩健合約條款的重要性。最終，貿易政策的轉變迫使相關人員採取更具韌性的籌資策略，並投資於能夠平衡成本控制、確保品質和業務連續性的合作關係。

將應用需求、最終用戶畫像、迴旋加速器能量等級、產品架構和通路與採購和營運優先順序相匹配的可操作細分智慧

透過精細的細分分析，可以揭示不同應用領域、最終用戶、迴旋加速器類型、產品架構和通路的需求促進因素和採購行為的差異。依應用領域分類，生產分為放射性藥物生產和科研應用，放射性藥物生產可進一步細分為診斷示蹤劑和治療性放射性同位素，二者在產量、品質和監管要求方面各有不同。最終用戶包括診斷影像中心、醫院、製藥公司和研究機構，它們各自擁有不同的資金限制、合規要求和營運優先級，這些因素決定了它們偏好的合約類型和服務水準。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 促進自動化放射性藥物工作流程與迴旋加速器系統的整合，提高處理效率和合規性。
  • 標靶技術的進步提高了新型放射性金屬在診療整合應用的產量。
  • 採用遠端監控和預測性維護工具，最大限度地減少迴旋加速器停機時間和故障。
  • 開發超緊湊型高能量迴旋加速器，以便在小型研究醫院進行現場生產。
  • 世界各地區為簡化迴旋加速器安裝核准而進行的監理協調工作
  • 神經影像學和腫瘤診斷市場的擴張將推動對碳-11和氟-18的需求。
  • 迴旋加速器製造商與製藥公司結成策略聯盟，旨在推動新型放射性示蹤劑研發。
  • 迴旋加速器設施正在轉型採用節能型冷卻和電力系統，以降低營運成本和占地面積。
  • 增加對迴旋加速器基礎設施的投資，以實現新興市場放射性藥物供應網路的去中心化。
  • 人工智慧驅動的製程最佳化技術的整合提高了迴旋加速器運行中同位素生產的產量和品管。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按應用程式分類的醫用迴旋加速器市場

  • 放射性藥物生產
    • 診斷追蹤器
    • 治療性放射性同位素
  • 研究用途

第9章 依最終用戶分類的醫用迴旋加速器市場

  • 診斷影像中心
  • 醫院
  • 製藥公司
  • 研究所

第10章 醫用迴旋加速器市場（依迴旋加速器型分類）

  • 高能量
  • 低能耗
  • 中等能量

第11章 醫用迴旋加速器市場（依產品分類）

  • 雙迴旋加速器
  • 單迴旋加速器

第12章 醫用迴旋加速器市場（依通路分類）

  • 通路夥伴
  • 直銷

第13章 區域性醫用迴旋加速器市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用迴旋加速器市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用迴旋加速器市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Ion Beam Applications SA
    • Sumitomo Heavy Industries, Ltd.
    • Siemens Healthineers AG
    • Advanced Cyclotron Systems Inc.
    • Best Theratronics Limited
    • Shimadzu Corporation
    • ACCEL Instruments GmbH
    • Huayi Isotope Co., Ltd.
    • EBARA Corporation
    • Niowave, Inc.
Product Code: MRR-957C47F92F8F

The Medical Cyclotron Market is projected to grow by USD 887.31 million at a CAGR of 10.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 387.35 million
Estimated Year [2025] USD 430.56 million
Forecast Year [2032] USD 887.31 million
CAGR (%) 10.91%

A strategic orientation to medical cyclotrons that clarifies their clinical roles, operational demands, and integration into contemporary radiopharmaceutical supply chains

The medical cyclotron sits at the intersection of clinical need and industrial capability, enabling the production of short lived radioisotopes that underpin contemporary diagnostic and therapeutic pathways. In recent years, advances in accelerator design, automation, and radiochemistry have shortened production cycles and increased the feasibility of localised isotope manufacture, shifting reliance away from extended distribution networks. This introduction sets the stage for understanding how cyclotron technologies integrate with radiopharmaceutical workflows, hospital nuclear medicine departments, and contract manufacturing operations.

Moreover, operational considerations such as facility siting, shielding and regulatory compliance shape both capital planning and day to day throughput. Patient centric drivers, including demands for precise diagnostic tracers and targeted therapeutics, create an accelerating need for flexible isotope production that can be synchronized with clinical schedules. Consequently, stakeholders from hospital administrators to pharmaceutical developers are recalibrating procurement and clinical supply strategies to capture the operational benefits inherent in modern cyclotron deployments.

The remainder of this executive summary explores the technical, commercial, and regulatory forces that are redefining cyclotron adoption, with an emphasis on pragmatic insights that support procurement decisions, clinical readiness, and partnerships across the radiopharmaceutical ecosystem.

How technological innovations, clinical demand, and evolving regulatory frameworks are converging to reshape cyclotron deployment models and operational strategies

The landscape for medical cyclotrons is experiencing transformative shifts driven by technological maturation, clinical demand, and evolving regulatory expectations. Improvements in compact cyclotron architecture and energy efficiency have broadened the range of viable installation sites, enabling diagnostic imaging centers and hospitals to weigh on site production against centralized supply models. Concurrently, automation of target handling, radiochemistry modules, and quality control systems is reducing operator dependency and enhancing reproducibility, which in turn supports multi shift operations and higher throughput.

At the same time, the radiopharmaceutical value chain is becoming more vertically integrated, with pharmaceutical companies and contract manufacturers investing in in house production capabilities to secure supply continuity for therapeutic and diagnostic tracers. This verticalization is complemented by strategic partnerships between cyclotron OEMs and radiochemistry vendors that accelerate technology transfer and shorten validation cycles. Regulatory frameworks are also adapting to new production paradigms; inspectors and certifying bodies are updating expectations for facility qualification, process validation, and sterility assurance, which increases the importance of design for compliance during early project planning.

Taken together, these shifts create an environment where technological capability, clinical need, and regulatory alignment converge to favor adaptable cyclotron solutions that can be scaled and validated rapidly. The net effect is a redistribution of risk and opportunity: clinical sites gain more control over their isotopic supply while manufacturers and service providers must demonstrate consistency and compliance to capture long term collaborations.

Understanding how recent tariff driven trade policy shifts are altering procurement economics, supply chain resilience, and aftermarket support for cyclotron infrastructure

Recent tariff actions originating in trade policy adjustments have introduced measurable complexity into the procurement and supply dynamics for cyclotron systems and ancillary equipment. Tariffs that affect imported components, precision machining, and select electronic subsystems have increased the landed cost and created incentives for suppliers to reassess their global manufacturing footprints. For procurement professionals, this has translated into a renewed focus on total cost of ownership analyses that incorporate customs duties, cross border logistics, and potential lead time variability.

At the supplier level, manufacturers are responding by diversifying suppliers, localizing assembly, and in some cases initiating partner agreements with regional fabricators to mitigate tariff exposure. These strategic moves help preserve margin and maintain competitive pricing but also introduce challenges related to quality control and regulatory documentation when components are sourced from new jurisdictions. For hospital and imaging center purchasers, the tariff environment has also encouraged exploration of service based arrangements and leasing models that can smooth capital expenditures and transfer certain currency and trade risks to vendors.

Operationally, tariffs have a downstream effect on spare parts availability and aftermarket service contracts. Facilities that operate legacy systems may encounter longer procurement cycles and higher costs for replacement parts, which in turn elevates the importance of preventive maintenance and inventory planning. In addition, the current trade landscape underscores the value of robust contractual terms that anticipate supply chain disruption and embed escalation clauses, preferential procurement options, and collaborative risk sharing between buyers and suppliers. Ultimately, trade policy shifts are compelling stakeholders to adopt more resilient sourcing strategies and to invest in relationships that balance cost control with assurances of quality and continuity.

Actionable segmentation intelligence that aligns application needs, end user profiles, cyclotron energy classes, product architectures, and distribution pathways with procurement and operational priorities

A refined segmentation lens reveals differentiated demand drivers and procurement behaviours across application, end user, cyclotron type, product architecture, and distribution channel. Based on Application, production is bifurcated into radiopharmaceutical production and research applications, with radiopharmaceutical production further divided into diagnostic tracers and therapeutic radioisotopes, which drive divergent throughput, quality and regulatory needs. Based on End User, the landscape includes diagnostic imaging centers, hospitals, pharmaceutical companies, and research institutes, each with unique capital constraints, compliance requirements, and operational priorities that dictate preferred contract structures and service levels.

Based on Cyclotron Type, the selection among high energy, medium energy, and low energy platforms reflects the isotopic portfolio targeted by the operator and the scale of production required. High energy systems enable a broader array of radioisotopes suitable for therapeutic applications, whereas low and medium energy systems are frequently optimized for routine diagnostic tracer manufacturing. Based on Product, procurement choices span single cyclotron deployments where capacity and cost efficiency are paramount versus dual cyclotron configurations that provide redundancy and increased scheduling flexibility, which is particularly important for high throughput clinical environments.

Finally, based on Distribution Channel, sales activity is channelled through direct sales relationships and channel partners, with direct sales often preferred for bespoke installations requiring extensive integration and local partnership coordination, while channel partners can accelerate market entry and provide localized service capabilities. Recognizing these segment distinctions helps stakeholders align technology selection, contractual design, and operational planning with their strategic objectives, thereby reducing implementation friction and improving service reliability.

Regional strategic considerations that reconcile regulatory diversity, clinical demand growth, and localized manufacturing capacity across major global markets

Regional dynamics exert a profound influence on infrastructure adoption, regulatory approach, and supply chain configuration across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, investment in localized production capacity is driven by dense clinical networks and an emphasis on reducing distribution lead times for short lived isotopes; capital availability and established regulatory pathways often facilitate rapid facility qualification. By contrast, the Europe, Middle East & Africa region presents a mosaic of regulatory regimes and reimbursement environments, where cross border collaboration and centralized manufacturing models remain important for cost efficiency and specialist isotope supply.

Asia-Pacific is characterized by rapidly expanding clinical demand, government initiatives to build domestic radiopharmaceutical capabilities, and a growing base of domestic equipment manufacturers that are enhancing regional supply security. Across regions, differences in workforce skill sets, radiation protection standards, and infrastructure funding mechanisms dictate tailored approaches to training, facility design, and long term service contracts. For multinational suppliers, these regional distinctions necessitate flexible business models that can accommodate localized regulatory documentation, regional partners for maintenance and qualification, and adaptive pricing strategies aligned with purchasing power and reimbursement frameworks.

Taken together, geographic nuance informs where investments in redundancy, local inventory, and regional centers of excellence will yield the greatest resilience and clinical impact. Transitioning from global templates to region specific strategies reduces deployment friction and accelerates time to clinical integration.

Competitive and partnership dynamics that shape supplier selection, after sales support models, and strategic alliances across the cyclotron and radiochemistry ecosystem

Competitive dynamics in the cyclotron ecosystem are shaped by a mix of established original equipment manufacturers, specialist radiochemistry suppliers, contract manufacturing organizations, and service integrators that together form an interdependent commercial network. Established OEMs compete on reliability, legacy installed base support, and engineering services, while newer entrants differentiate through compact designs, automation, and cost effective service models. Radiochemistry vendors and module providers play a critical role in turnkey solutions, enabling faster validation and compliance for clinical tracer production.

Partnerships and strategic alliances are common, with OEMs collaborating with radiopharmaceutical developers to co validate isotope production pathways and with service providers to offer managed production contracts. Similarly, contract development and manufacturing organizations expand access to therapeutic isotopes by providing GMP compliant suites and validated radiochemistry workflows that reduce the entry barrier for smaller pharmaceutical developers. Service models are evolving from reactive maintenance to predictive and subscription based support, leveraging remote diagnostics and telemetry to minimize downtime and extend equipment life.

For buyers evaluating suppliers, differentiation should be assessed across four dimensions: engineering robustness and uptime performance; depth of regulatory and quality documentation support; aftermarket service coverage and spare part logistics; and the supplier's ability to support process transfer for both diagnostic and therapeutic isotopes. These criteria guide procurement to partners that can de risk implementation, accelerate clinical readiness, and provide long term operational assurance.

Actionable operational and procurement recommendations that optimize facility design, service arrangements, workforce capability, and supply chain resilience for cyclotron deployments

Industry leaders must adopt pragmatic, forward looking actions to capture clinical value while mitigating operational risk. First, prioritize integration planning that aligns facility design with regulatory expectations and clinical scheduling, including early engagement with radiation safety officers and quality teams to streamline qualification. Second, favor modular and upgradeable cyclotron architectures that permit phased investment, enabling organizations to scale isotopic capabilities as clinical demand evolves without incurring prohibitive early capital commitments.

Third, negotiate service arrangements that include defined response times, critical spare inventories, and options for remote monitoring to preserve uptime. Fourth, pursue collaborative procurement and shared supply models among regional clinical networks to optimize utilization and reduce per unit production costs while maintaining compliance. Fifth, invest in workforce development and cross functional training across operations, radiochemistry, and quality assurance to sustain consistent production and regulatory readiness.

Finally, incorporate scenario based supply chain planning that tests the resilience of sourcing options and identifies critical single points of failure. By executing these recommendations, industry participants can reduce implementation friction, strengthen supply continuity, and position themselves to respond rapidly to evolving clinical needs and regulatory expectations.

A rigorous multi method research approach that integrates stakeholder interviews, technical literature, and case based validation to produce actionable and reproducible insights

The research synthesis that informs this executive summary combined qualitative expert interviews, technical literature review, and primary engagement with equipment designers, clinical operators, and radiopharmaceutical developers. Interviews were conducted with a cross section of stakeholders to capture operational experience, procurement decision criteria, and regulatory pain points. Technical literature and regulatory guidance documents were reviewed to validate engineering constraints, validation expectations, and radiation protection standards.

Analytical methods emphasized triangulation: qualitative insights from interviews were cross referenced with documented regulatory requirements and vendor technical specifications to ensure coherence. Case studies of recent installations were examined to extract best practices in facility layout, shielding design, and radiochemistry workflow integration. Sensitivity checks were applied to assumptions about lead times, service coverage, and component sourcing to identify key risk vectors affecting deployment and continuity.

Throughout the methodology, emphasis was placed on reproducibility and traceability of findings. Data sources and interview protocols were selected to provide balanced perspectives across clinical, commercial, and regulatory domains, and conclusions were tempered to reflect operational realities rather than hypothetical constructs. The approach privileges actionable insight and pragmatic guidance to support decision makers in procurement, clinical operations, and strategic planning roles.

Concluding synthesis that reframes cyclotron investment as a strategic capability enabling clinical innovation, supply resilience, and operational excellence

In conclusion, medical cyclotron deployment represents a strategic capability that aligns clinical demand for advanced diagnostics and therapeutics with an increasingly sophisticated manufacturing and regulatory environment. Technological advances have expanded where and how isotopes can be produced, while trade policy and procurement considerations require more nuanced sourcing strategies. Successful adoption depends on integrating facility design, regulatory planning, workforce development, and durable supplier relationships to ensure consistent clinical supply.

Decision makers should view cyclotron investments not only as capital purchases but as anchors for broader radiopharmaceutical strategy, enabling local innovation, improving patient access, and creating operational resilience. By following the evidence based recommendations outlined here-emphasizing modular design, robust service agreements, collaborative procurement, and workforce training-organizations can reduce implementation risk and accelerate clinical benefit delivery.

This executive summary provides a foundation for deeper engagement with the detailed report, which contains implementation checklists, technical annexes, and supplier evaluation frameworks to support procurement and operational teams as they translate strategy into practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing integration of automated radiopharmacy workflows with cyclotron systems to boost throughput and compliance
  • 5.2. Emergence of solid targetry advancements enhancing yield of novel radiometals for theranostic applications
  • 5.3. Adoption of remote monitoring and predictive maintenance tools for minimizing cyclotron downtime and errors
  • 5.4. Development of ultra-compact high-energy cyclotrons enabling on-site production in small research hospitals
  • 5.5. Regulatory harmonization efforts streamlining cyclotron installation approvals across different global regions
  • 5.6. Demand growth for carbon-11 and fluorine-18 driven by expanding market for neuroimaging and oncology diagnostics
  • 5.7. Strategic partnerships between cyclotron manufacturers and pharmaceutical companies targeting novel radiotracer pipelines
  • 5.8. Shift towards energy-efficient cooling and power systems in cyclotron facilities to reduce operational costs and footprint
  • 5.9. Rising investments in cyclotron infrastructure within emerging markets to decentralize radiopharmaceutical supply networks
  • 5.10. Integration of AI-driven process optimization to enhance isotope production yield and quality control in cyclotron operations

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Cyclotron Market, by Application

  • 8.1. Radiopharmaceutical Production
    • 8.1.1. Diagnostic Tracers
    • 8.1.2. Therapeutic Radioisotopes
  • 8.2. Research Applications

9. Medical Cyclotron Market, by End User

  • 9.1. Diagnostic Imaging Centers
  • 9.2. Hospitals
  • 9.3. Pharmaceutical Companies
  • 9.4. Research Institutes

10. Medical Cyclotron Market, by Cyclotron Type

  • 10.1. High Energy
  • 10.2. Low Energy
  • 10.3. Medium Energy

11. Medical Cyclotron Market, by Product

  • 11.1. Dual Cyclotron
  • 11.2. Single Cyclotron

12. Medical Cyclotron Market, by Distribution Channel

  • 12.1. Channel Partners
  • 12.2. Direct Sales

13. Medical Cyclotron Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Cyclotron Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Cyclotron Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Ion Beam Applications S.A.
    • 16.3.2. Sumitomo Heavy Industries, Ltd.
    • 16.3.3. Siemens Healthineers AG
    • 16.3.4. Advanced Cyclotron Systems Inc.
    • 16.3.5. Best Theratronics Limited
    • 16.3.6. Shimadzu Corporation
    • 16.3.7. ACCEL Instruments GmbH
    • 16.3.8. Huayi Isotope Co., Ltd.
    • 16.3.9. EBARA Corporation
    • 16.3.10. Niowave, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MEDICAL CYCLOTRON MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MEDICAL CYCLOTRON MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL CYCLOTRON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC TRACERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY THERAPEUTIC RADIOISOTOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HIGH ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY LOW ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY MEDIUM ENERGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DUAL CYCLOTRON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SINGLE CYCLOTRON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY CHANNEL PARTNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 110. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 111. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 114. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 128. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 228. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 237. GCC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GCC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GCC MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. GCC MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. GCC MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 242. GCC MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 243. GCC MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. GCC MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GCC MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 248. GCC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 249. GCC MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. GCC MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 270. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 271. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 276. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 277. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. BRICS MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 279. G7 MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. G7 MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. G7 MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. G7 MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. G7 MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 284. G7 MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 285. G7 MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. G7 MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. G7 MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. G7 MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. G7 MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 290. G7 MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 291. G7 MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 292. G7 MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 293. NATO MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. NATO MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. NATO MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NATO MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NATO MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 298. NATO MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 299. NATO MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. NATO MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. NATO MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. NATO MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. NATO MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 304. NATO MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 305. NATO MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. NATO MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 313. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 318. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 319. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 320. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 321. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 322. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 323. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 324. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 325. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY CYCLOTRON TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 330. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 331. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 332. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 333. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 334. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 335. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
  • TABLE 336. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY RADIOPHARMACEUTICAL PRODUCTION, 2025-2032 (USD MILLION)
  • TABLE 337. MEXICO MEDICAL CYCL